BBIO

Stock Market

BridgeBio Stock Surges on Dwarfism Drug Data. It’s Bad News for BioMarin.

[ad_1] BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for…

Read More »
Back to top button
Close